LIGAND PHARMACEUTICALS INCORPORATED Finance Lease, Interest Payment on Liability
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Finance Lease, Interest Payment on Liability of $20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED finance lease, interest payment on liability for fiscal 2025 was $20.00K, a 0.00% change from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED finance lease, interest payment on liability for fiscal 2024 was $20.00K, a 60.00% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED finance lease, interest payment on liability for fiscal 2023 was $50.00K, a 0.00% change from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED finance lease, interest payment on liability for fiscal 2022 was $50.00K, a 99.46% decline from fiscal 2021.
| Period end | Finance Lease, Interest Payment on Liability 12 month |
|---|---|
| 2025-12-31 | $20.00K 10-K · filed 2026-02-27 |
| 2024-12-31 | $20.00K 10-K · filed 2026-02-27 |
| 2023-12-31 | $50.00K 10-K · filed 2026-02-27 |
| 2022-12-31 | $50.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | $9.30M 10-K · filed 2023-02-28 |
| 2020-12-31 | $9.70M 10-K · filed 2022-02-28 |